Jane Street Group, LLC Neoleukin Therapeutics, Inc. Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.4 - $0.55 $24,266 - $33,366	60,667 New	60,667 $30,000
Q3 2020 Nov 17, 2020	SELL	$9.68 - $17.01 $416,036 - $731,072	-42,979 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$9.95 - $17.05 $26,486 - $45,387	2,662 Added 6.6%	42,979 $714,000
Q1 2020 May 15, 2020	BUY	$6.12 - $13.64 $246,740 - $549,923	40,317 New	40,317 $459,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.